Trikafta Question

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

2 posts / 0 new
Last post
Emily K D'Anna
Emily K D'Anna's picture
Offline
Last seen: 2 weeks 2 days ago
Joined: 02/07/2017 - 11:38
Trikafta Question

Hello! Interesting, niche, question from one of our safety-minded outpatient pharmacists regarding the medication Trikafta (elexacaftor, tezacaftor, ivacaftor) for management of CF.

Curious if anyone else has come up with a solution to safely / accurately prescribe and document this medication when dose adjustments are indicated.

This med is supplied as 2 separate products packaged together in a blister card package containing 21 tablets: elexacafter/tezacaftor/ivacaftor (orange capsule-shaped tablet) in fixed-dose combination and ivacaftor (blue capsule-shaped tablets)

Since retail pharmacies likely end up needing to dispense the full blister card package…. when dosing is modified to omit tablets or adjust dosing frequency, prescribers are running into hiccups with dispensing pharmacies / insurance providers leading to potentially inaccurate administration instructions / med lists in the name of simplifying prescribing. (i.e., prescribing the full blister package and capturing dosing recommendations / changes just in notes) (also potential for inaccuracies during med reconciliation, in and out of hospital, etc.)

Curious if others have any experience with this issue and have identified any recommendations around prescribing approach. Or if there is concern about the packaging being inflexible.

thanks in advance!
Emily

Tags: